INS webinars deliver the most current infusion-related topics in a 60-minute presenter-led session. Each webinar is delivered live and then archived for on-demand viewing.

Webinars

  • Short Peripheral Catheter Infiltration: Minimizing Risks to Improve Outcomes

    Contains 3 Component(s), 1 credit offered Includes a Live Event on 02/13/2019 at 1:00 PM (EST)

    Sponsored by: ivWatch

    Hospitalized patients receiving medications or fluids via short peripheral catheters (SPCs) are at risk for infiltration. Infiltration can increase patient length of stay, result in repeated vascular access procedures, increase costs by use of supplies and nursing time, lead to short-term and long-term patient harm, and decrease patient satisfaction. Early detection of infiltration can minimize risks by prompt intervention. Quality improvement projects have been directed toward staff education on SPC insertion, maintenance, assessment, and monitoring. This webinar will discuss current research and practice initiatives, as well as the benefits of emerging technology aimed at reducing infiltration.

    Learning Outcomes:
    At the conclusion of this presentation, participants will be able to:
    1. Identify risk factors associated with SPC infiltration
    2. Describe the benefits of early and ongoing assessment to detect infiltration 

    Sponsored by: ivWatch

    Hospitalized patients receiving medications or fluids via short peripheral catheters (SPCs) are at risk for infiltration. Infiltration can increase patient length of stay, result in repeated vascular access procedures, increase costs by use of supplies and nursing time, lead to short-term and long-term patient harm, and decrease patient satisfaction. Early detection of infiltration can minimize risks by prompt intervention. Quality improvement projects have been directed toward staff education on SPC insertion, maintenance, assessment, and monitoring. This webinar will discuss current research and practice initiatives, as well as the benefits of emerging technology aimed at reducing infiltration.

    Learning Outcomes:
    At the conclusion of this presentation, participants will be able to:
    1. Identify risk factors associated with SPC infiltration
    2. Describe the benefits of early and ongoing assessment to detect infiltration 

    Grergory Schears, MD

    Mayo Clinic

    Gregory J. Schears, MD, is a pediatric intensivist and anesthesiologist at the Mayo Clinic in Rochester, Minnesota. He has had a long-standing interest in reducing patient complications and improving the approach to vascular access. He is a consultant to the department of anesthesiology and the division of pediatric critical care medicine, the physician liaison to the nurse-led peripherally inserted central catheter team, and is also the comedical director of the cardiovascular pediatric surgical intensive care unit. An associate  professor of anesthesiology, Dr. Schears has presented locally, regionally, nationally, and internationally.

    Disclosure: ivWatch; Consultant Fee; COI resolved

    CRNI® Recerts: This session has been approved for 1 CRNI® recertification unit

    Contact Hours/CE Credits: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: February 13, 2022

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.


    INS is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

  • Bleeding Disorders: Management of Pediatric Patients

    Contains 3 Component(s), 1 credit offered Recorded On: 01/16/2019

    Bleeding disorders are rare and complex, and to some nurses, frightening. The information in this presentation is designed to introduce and discuss the management of pediatric patients with a bleeding disorder. Infusion nurses are key to high-quality care in the home setting. Therefore, bleeding disorder-specific education is critical in the implementation and delivery of excellent nursing care. During this presentation, participants will explore the classifications of bleeding disorders, review laboratory tests necessary for diagnosing a bleeding disorder, and discuss current and emerging treatment options, as well as complications associated with bleeding disorders. 

    Learning Outcomes: 
    At the conclusion of this presentation, participants will be able to:
    • Describe the classifications of hemophilia A, hemophilia B, and von Willebrand disease (VWD).
    • Recall the types of screening for hemophilia A, B, and vWD.
    • Discuss the treatment for hemophilia A, hemophilia B, and vWD.
    • Recognize signs and symptoms of complications in pediatric patients with a bleeding disorder.

    Bleeding disorders are rare and complex, and to some nurses, frightening. The information in this presentation is designed to introduce and discuss the management of pediatric patients with a bleeding disorder. Infusion nurses are key to high-quality care in the home setting. Therefore, bleeding disorder-specific education is critical in the implementation and delivery of excellent nursing care. During this presentation, participants will explore the classifications of bleeding disorders, review laboratory tests necessary for diagnosing a bleeding disorder, and discuss current and emerging treatment options, as well as complications associated with bleeding disorders. 

    Learning Outcomes: 
    At the conclusion of this presentation, participants will be able to:
    • Describe the classifications of hemophilia A, hemophilia B, and von Willebrand disease (VWD).
    • Recall the types of screening for hemophilia A, B, and vWD.
    • Discuss the treatment for hemophilia A, hemophilia B, and vWD.
    • Recognize signs and symptoms of complications in pediatric patients with a bleeding disorder.

    Ashley Smith, MSN, RN, CRNI®

    Nurse Specialist, Bleeding Disorders

    Ashley Smith, MSN, RN, CRNI®, is a nurse specialist in bleeding disorder therapies at Paragon Healthcare Specialty. Before her career in specialty pharmacy, Mrs. Smith spent many years caring for pediatric and adult patients in the emergency department. She has also worked in cardiology, general medicine, and outpatient surgery. She earned a bachelor’s degree from Jacksonville State University and an MSN in nursing education from the University of North Alabama. She is a member of the Sigma Theta Tau International Honor Society of Nursing, now known as Sigma. 

    Disclosure: No conflict of interest to disclose

    CRNI® Recerts: This session has been approved for 1 CRNI® recertification unit

    Contact Hours/CE Credits: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: January 16, 2022

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.


    INS is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

  • Infusion Therapy in Alternative Care Settings

    Contains 3 Component(s), 1 credit offered Recorded On: 12/12/2018

    Administering infusion therapy in alternative care settings requires expert planning and management. Infusion nurses must be knowledgeable when providing care for patients in home, hospice, and other non-acute facilities. This webinar will address best practices for attaining and maintaining vascular access, administration of infusion therapy, and safety and infection control in alternative care settings. 

    Learning Outcomes:
    At the conclusion of this webinar, attendees will:
    a) be able to describe best practices for attaining and maintaining vascular access in alternate care settings and 
    b) identify safety and infection control practices for alternative care settings. 

    Administering infusion therapy in alternative care settings requires expert planning and management. Infusion nurses must be knowledgeable when providing care for patients in home, hospice, and other non-acute facilities. This webinar will address best practices for attaining and maintaining vascular access, administration of infusion therapy, and safety and infection control in alternative care settings. 

    Learning Outcomes:
    At the conclusion of this webinar, attendees will:
    a) be able to describe best practices for attaining and maintaining vascular access in alternate care settings and 
    b) identify safety and infection control practices for alternative care settings. 

    Jan Elliott, BS, RN, CRNI®, VA-BC

    Infusion Therapy and Vascular Access Specialist

    Jan Elliott, BS, RN, CRNI®, VA-BC, is an infusion therapy and vascular access specialist, and the primary hospice and palliative care on-call nurse for Upstate Homecare in Central New York. Throughout her 24-year career, Jan has administered infusion therapy, developed vascular access teams, and provided education for clinicians on pain management in the home, alternative, and acute care settings. She has also worked for various US medical device companies as a clinical specialist, preceptor, and educator. In those roles, Jan helped implement conversions on new technologies, products, and services with a focus on promoting and ensuring safer, effective, and efficient delivery of patient care. Jan has been president of the Association of Vascular Access of Central New York for the past 10 years, and has hosted a teaching day symposium for all health care disciplines with discussions on best practices, innovations, and evidence-based medicine. 

    Disclosure: No conflict of interest to disclose

    CRNI® Recerts: This session has been approved for 1 CRNI® recertification unit

    Contact Hours/CE Credits: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: December 12, 2021

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.


    INS is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

  • CAR T-Cells: Treatment Overview, Toxicity Management, and Administration Considerations

    Contains 3 Component(s), 1 credit offered Recorded On: 11/14/2018

    Chimeric antigen receptor (CAR) T-cells are cellular immunotherapies used for the treatment of some malignancies. This adoptive cell therapy represents a new paradigm in cancer treatment, one in which the patient’s own immune system, specifically T-cells, are engineered to treat his or her cancer. CAR T-cell therapy is a complex treatment associated with unique and serious toxicities, making education a necessity for both the patient and the health care provider. This presentation will provide an overview of CAR T-cell therapy, toxicity assessment and management strategies, administration considerations, and patient education needs for the health care provider.  

    Learning Outcomes: At the conclusion of this presentation, learners will be able to:
    • Describe the mechanism of action for CAR T-cells
    • Identify 3 common toxicities associated with CAR T-cells, as well as associated management strategies 
    • Verbalize administration considerations for CAR T-cell products

    Chimeric antigen receptor (CAR) T-cells are cellular immunotherapies used for the treatment of some malignancies. This adoptive cell therapy represents a new paradigm in cancer treatment, one in which the patient’s own immune system, specifically T-cells, are engineered to treat his or her cancer. CAR T-cell therapy is a complex treatment associated with unique and serious toxicities, making education a necessity for both the patient and the health care provider. This presentation will provide an overview of CAR T-cell therapy, toxicity assessment and management strategies, administration considerations, and patient education needs for the health care provider.  

    Learning Outcomes: At the conclusion of this presentation, learners will be able to:
    • Describe the mechanism of action for CAR T-cells
    • Identify 3 common toxicities associated with CAR T-cells, as well as associated management strategies 
    • Verbalize administration considerations for CAR T-cell products

    Karen Anderson, MN, RN, AOCNS, BMTCN, CRNI®

    Infusion Manager

    Karen Anderson, MN, RN, AOCNS, BMTCN, CRNI®, is an infusion manager at the Banner University of Arizona Cancer Center in Tucson, Arizona. Previously, she was the clinical operations manager at the Bezos Family Immunotherapy Clinic at the Seattle Cancer Care Alliance, a clinic dedicated to supporting scientific advances in cellular immunotherapies and affiliated with the Fred Hutchison Cancer Research Center and the University of Washington. Her professional background includes roles in inpatient and ambulatory settings as a staff nurse, research nurse, and an oncology clinical nurse specialist. Ms. Anderson is currently a PhD student in nursing at the University of Arizona. 

    Disclosure: Kite Pharma- A Gilead Company; Consultant Fee; COI resolved

    CRNI® Recerts: This session has been approved for 1 CRNI® recertification unit

    Contact Hours/CE Credits: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: November 14, 2021

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.



    INS is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.



  • The Normalization of Deviance in Health Care Delivery: Insights on Prevention, Learning, and Corrective Action From Organizational Science

    Contains 3 Component(s), 1 credit offered Recorded On: 10/17/2018

    In today’s health care climate, normalized deviation from established standards of practice is the focus of considerable research and practical intervention. It is now widely recognized that medical errors, workarounds, and adverse drug events are often caused by cultural norms and institutionalized patterns of behavior developed over time. Yet despite this recognition, most organizations encounter significant barriers to changing these normative pressures. In this webinar, change management tools and principles from the organizational sciences will be provided to help participants prevent, minimize, and correct the negative consequences of normative deviance. 

    Learning Outcomes: At the conclusion of this presentation, participants will be able to:
    • Diagnose problems associated with normative deviance.
    • Gain exposure to contemporary change-management models.
    • Understand basic intervention strategies for overcoming dysfunctional deviance.

    In today’s health care climate, normalized deviation from established standards of practice is the focus of considerable research and practical intervention. It is now widely recognized that medical errors, workarounds, and adverse drug events are often caused by cultural norms and institutionalized patterns of behavior developed over time. Yet despite this recognition, most organizations encounter significant barriers to changing these normative pressures. In this webinar, change management tools and principles from the organizational sciences will be provided to help participants prevent, minimize, and correct the negative consequences of normative deviance. 

    Learning Outcomes: At the conclusion of this presentation, participants will be able to:
    • Diagnose problems associated with normative deviance.
    • Gain exposure to contemporary change-management models.
    • Understand basic intervention strategies for overcoming dysfunctional deviance.

    Benjamin Dunford, PhD, MS, BS

    Associate Professor

    Benjamin Dunford, PhD, MS, BS, is an associate professor at the Krannert School of Management of Purdue University. He also has formal academic affiliations with Purdue’s department of psychological sciences and Regenstrief Center for Healthcare Engineering, and with the school of management at Seoul National University in South Korea. Professor Dunford is a recognized teacher at the master’s and executive levels on topics that include negotiation, organizational change, leadership, employee engagement, and conflict management. His research, which has been recognized for excellence, focuses on how management of people has an impact on organizational effectiveness, employee engagement, and safety outcomes, with a special emphasis on the health care industry. The author of more than 25 published peer reviewed journal articles, conference proceedings, and book chapters, Professor Dunford has consulted with numerous firms from a variety of industries, but most extensively in health care. 

    CRNI® Recerts: This session has been approved for 1 CRNI® recertification unit

    Contact Hours/CE Credits: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: October 17, 2021